Search results
Results from the WOW.Com Content Network
Another potential competitor is OncoGenex Pharmaceuticals. OncoGenex has an ongoing phase 3 study evaluating custirsen, used with docetaxol, in mCRPC. Data from this trial is expected in the first ...
Custirsen, with aliases including custirsen sodium, OGX-011, and CC-8490, is an investigational drug that is under clinical testing for the treatment of cancer.It is an antisense oligonucleotide (ASO) targeting clusterin expression. [1]
Onyx Pharmaceuticals Inc. has been a biopharmaceutical company headquartered in South San Francisco, California. The company developed and marketed medicines for the treatment of cancer. Onyx was founded in 1992 by Kevin J. Kinsella and Frank McCormick Ph.D., FRS. [1]
Nelson established the Australian Prostate Cancer Research Centre – Queensland in 2007, and was a co-founder of the Vancouver Prostate Centre in 1998. [4] She founded and is the director of the Federal Government funded Australian-Canadian Prostate Cancer Research Alliance, a global network of researchers, clinicians, academics, and scientists who work in prostate cancer research.
For premium support please call: 800-290-4726 more ways to reach us
For premium support please call: 800-290-4726 more ways to reach us
Nicholas J. Vogelzang was a medical oncologist with Comprehensive Cancer Centers of Nevada (CCCN). He serves as medical director of the Research Executive Committee and Associate Chair of the Developmental Therapeutics and Genitourinary Committees for US Oncology Research.
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.